EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 9.41 BATS BZX Real-Time Price As of 2:34pm ET |  -0.37 / -3.78%Today’s Change | 3.51 Today|||52-Week Range 15.06 | +43.01% Year-to-Date |
Latest EYPT News | Press Releases
| EyePoint Pharmaceuticals Stock Is Believed To Be Possible Value Trap Jun 16 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 9.78 |
| Today’s open | 9.86 |
| Day’s range | 9.33 - 9.86 |
| Volume | 1,919 |
| Average volume (3 months) | 225,521 |
| Market cap | $273.0M |
Data as of 2:34pm ET, 06/17/2021
Growth & Valuation
| Earnings growth (last year) | +35.05% |
| Earnings growth (this year) | +48.82% |
| Earnings growth (next 5 years) | +18.70% |
| Revenue growth (last year) | +69.10% |
| P/E ratio | NM |
| Price/Sales | 2.45 |
| Price/Book | 9.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MBIOMustang Bio Inc | -0.06 | -1.73% |
| TRVNTrevena Inc | -0.10 | -5.22% |
| ONCTOncternal Therapeuti... | -0.09 | -1.67% |
| INFIInfinity Pharmaceuti... | -0.04 | -1.05% |
Data as of 2:35pm ET, 06/17/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $34.4M |
| Annual profit (last year) | -$45.4M |
| Net profit margin | -131.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
